Search

Andrew P. Lee

Examiner (ID: 15977)

Most Active Art Unit
1621
Art Unit(s)
1628, 1629, 1691, 1621
Total Applications
704
Issued Applications
285
Pending Applications
97
Abandoned Applications
333

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14990671 [patent_doc_number] => 20190314293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => LOXAPINE FILM ORAL DOSAGE FORM [patent_app_type] => utility [patent_app_number] => 16/455916 [patent_app_country] => US [patent_app_date] => 2019-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3070 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 239 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16455916 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/455916
LOXAPINE FILM ORAL DOSAGE FORM Jun 27, 2019 Abandoned
Array ( [id] => 17520447 [patent_doc_number] => 20220106296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => CYANOTRIAZOLE COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/253737 [patent_app_country] => US [patent_app_date] => 2019-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31398 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253737 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/253737
CYANOTRIAZOLE COMPOUNDS AND USES THEREOF Jun 17, 2019 Abandoned
Array ( [id] => 15239447 [patent_doc_number] => 20190374509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-12 [patent_title] => Methods of Using Metamizole for Treatment of Pyrexia in Equines [patent_app_type] => utility [patent_app_number] => 16/438130 [patent_app_country] => US [patent_app_date] => 2019-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12105 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16438130 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/438130
Methods of Using Metamizole for Treatment of Pyrexia in Equines Jun 10, 2019 Abandoned
Array ( [id] => 16992260 [patent_doc_number] => 20210230680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => Modified Nucleobases with Uniform H-Bonding Interactions, Homo- and Hetero-Basepair Bias, and Mismatch Discrimination [patent_app_type] => utility [patent_app_number] => 16/972873 [patent_app_country] => US [patent_app_date] => 2019-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9346 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -48 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16972873 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/972873
Modified Nucleobases with Uniform H-Bonding Interactions, Homo- and Hetero-Basepair Bias, and Mismatch Discrimination Jun 6, 2019 Pending
Array ( [id] => 15264567 [patent_doc_number] => 20190381017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => Compositions Comprising Serdexmethylphenidate Conjugates And Methods Of Use Thereof [patent_app_type] => utility [patent_app_number] => 16/433525 [patent_app_country] => US [patent_app_date] => 2019-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45579 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -78 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16433525 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/433525
Compositions Comprising Serdexmethylphenidate Conjugates And Methods Of Use Thereof Jun 5, 2019 Abandoned
Array ( [id] => 16990111 [patent_doc_number] => 20210228531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => TARGETED TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER NEUROLOGICAL OR PSYCHIATRIC DISORDERS [patent_app_type] => utility [patent_app_number] => 15/734843 [patent_app_country] => US [patent_app_date] => 2019-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23328 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734843 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/734843
TARGETED TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER NEUROLOGICAL OR PSYCHIATRIC DISORDERS Jun 4, 2019 Pending
Array ( [id] => 17005277 [patent_doc_number] => 20210236438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => COMPOUNDS AND METHODS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER NEUROLOGICAL OR PSYCHIATRIC DISORDERS [patent_app_type] => utility [patent_app_number] => 15/734869 [patent_app_country] => US [patent_app_date] => 2019-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7779 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734869 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/734869
COMPOUNDS AND METHODS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER NEUROLOGICAL OR PSYCHIATRIC DISORDERS Jun 4, 2019 Pending
Array ( [id] => 16822645 [patent_doc_number] => 20210137938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => NUPR1 INHIBITION FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 17/059297 [patent_app_country] => US [patent_app_date] => 2019-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7756 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 244 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059297 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/059297
NUPR1 INHIBITION FOR TREATING CANCER May 30, 2019 Pending
Array ( [id] => 20414124 [patent_doc_number] => 12497394 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-16 [patent_title] => Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereof [patent_app_type] => utility [patent_app_number] => 17/057199 [patent_app_country] => US [patent_app_date] => 2019-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15368 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 505 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057199 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/057199
Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereof May 20, 2019 Issued
Array ( [id] => 15206013 [patent_doc_number] => 20190365693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-05 [patent_title] => INDUCTION OF ARTERIOGENESIS [patent_app_type] => utility [patent_app_number] => 16/412749 [patent_app_country] => US [patent_app_date] => 2019-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14424 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16412749 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/412749
INDUCTION OF ARTERIOGENESIS May 14, 2019 Abandoned
Array ( [id] => 19491866 [patent_doc_number] => 12110564 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-08 [patent_title] => Test to distinguish viral-only from bacterial infection or viral/bacterial coinfection using a respiratory swab [patent_app_type] => utility [patent_app_number] => 17/052882 [patent_app_country] => US [patent_app_date] => 2019-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7797 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052882 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/052882
Test to distinguish viral-only from bacterial infection or viral/bacterial coinfection using a respiratory swab May 5, 2019 Issued
Array ( [id] => 16655892 [patent_doc_number] => 20210052528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => THE USE OF SGC ACTIVATORS AND SGC STIMULATORS FOR THE TREATMENT OF COGNITIVE IMPAIRMENT [patent_app_type] => utility [patent_app_number] => 17/051060 [patent_app_country] => US [patent_app_date] => 2019-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13193 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17051060 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/051060
THE USE OF SGC ACTIVATORS AND SGC STIMULATORS FOR THE TREATMENT OF COGNITIVE IMPAIRMENT Apr 11, 2019 Abandoned
Array ( [id] => 18215181 [patent_doc_number] => 11590093 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-28 [patent_title] => Kit, composition, and combination therapy for fragile X syndrome [patent_app_type] => utility [patent_app_number] => 16/383037 [patent_app_country] => US [patent_app_date] => 2019-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 28 [patent_no_of_words] => 8161 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383037 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/383037
Kit, composition, and combination therapy for fragile X syndrome Apr 11, 2019 Issued
Array ( [id] => 16374948 [patent_doc_number] => 20200323790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-15 [patent_title] => METHOD FOR TREATMENT OF ACUTE LUNG INJURY BY USE OF KIRENOL [patent_app_type] => utility [patent_app_number] => 16/382662 [patent_app_country] => US [patent_app_date] => 2019-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2290 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382662 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/382662
METHOD FOR TREATMENT OF ACUTE LUNG INJURY BY USE OF KIRENOL Apr 11, 2019 Abandoned
Array ( [id] => 15586247 [patent_doc_number] => 20200069658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-05 [patent_title] => COMBINATION THERAPY FOR PULMONARY HYPERTENSION [patent_app_type] => utility [patent_app_number] => 16/381128 [patent_app_country] => US [patent_app_date] => 2019-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8972 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381128 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/381128
COMBINATION THERAPY FOR PULMONARY HYPERTENSION Apr 10, 2019 Abandoned
Array ( [id] => 16596510 [patent_doc_number] => 20210023041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => FORMULATIONS AND COMPOSITIONS OF DOCETAXEL [patent_app_type] => utility [patent_app_number] => 16/982772 [patent_app_country] => US [patent_app_date] => 2019-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44214 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982772 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/982772
FORMULATIONS AND COMPOSITIONS OF DOCETAXEL Apr 10, 2019 Abandoned
Array ( [id] => 16374966 [patent_doc_number] => 20200323808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-15 [patent_title] => WOUND TREATMENTS AND COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/381975 [patent_app_country] => US [patent_app_date] => 2019-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18990 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381975 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/381975
Wound treatments and compositions Apr 10, 2019 Issued
Array ( [id] => 16533276 [patent_doc_number] => 10875859 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-29 [patent_title] => Thymoquinone/harmaline and related reaction products [patent_app_type] => utility [patent_app_number] => 16/380279 [patent_app_country] => US [patent_app_date] => 2019-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 8044 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16380279 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/380279
Thymoquinone/harmaline and related reaction products Apr 9, 2019 Issued
Array ( [id] => 15586171 [patent_doc_number] => 20200069620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-05 [patent_title] => COMPOSITION AND METHOD FOR MUSCLE REPAIR AND REGENERATION [patent_app_type] => utility [patent_app_number] => 16/379178 [patent_app_country] => US [patent_app_date] => 2019-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20743 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16379178 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/379178
Composition and method for muscle repair and regeneration Apr 8, 2019 Issued
Array ( [id] => 16726444 [patent_doc_number] => 20210093591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-01 [patent_title] => METHODS FOR MITIGATING AND PREVENTING PROTEOSTASIS-BASED INJURIES [patent_app_type] => utility [patent_app_number] => 17/043966 [patent_app_country] => US [patent_app_date] => 2019-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21406 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17043966 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/043966
METHODS FOR MITIGATING AND PREVENTING PROTEOSTASIS-BASED INJURIES Mar 28, 2019 Abandoned
Menu